Vik Chopra
Stock Analyst at Wells Fargo
(1.92)
# 2,824
Out of 4,814 analysts
36
Total ratings
33.33%
Success rate
-3.03%
Average return
Main Sectors:
Stocks Rated by Vik Chopra
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SOLV Solventum | Maintains: Equal-Weight | $73 → $75 | $65.70 | +14.16% | 3 | Feb 28, 2025 | |
| XRAY DENTSPLY SIRONA | Maintains: Equal-Weight | $20 → $19 | $12.84 | +47.98% | 2 | Feb 28, 2025 | |
| MASI Masimo | Maintains: Overweight | $193 → $205 | $152.40 | +34.51% | 8 | Feb 26, 2025 | |
| GMED Globus Medical | Maintains: Overweight | $95 → $93 | $72.35 | +28.54% | 9 | Feb 21, 2025 | |
| ALGN Align Technology | Initiates: Overweight | $255 | $171.41 | +48.77% | 1 | Feb 14, 2025 | |
| HSIC Henry Schein | Initiates: Equal-Weight | $80 | $64.28 | +24.46% | 1 | Feb 14, 2025 | |
| CNMD CONMED | Maintains: Equal-Weight | $74 → $70 | $48.54 | +44.21% | 3 | Feb 6, 2025 | |
| NVST Envista Holdings | Maintains: Equal-Weight | $20 → $21 | $15.19 | +38.25% | 2 | Feb 6, 2025 | |
| NPCE NeuroPace | Maintains: Overweight | $15 → $13 | $10.80 | +20.37% | 2 | Nov 13, 2024 | |
| ATEC Alphatec Holdings | Maintains: Overweight | $26 → $19 | $10.54 | +80.35% | 1 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $45 → $25 | $15.80 | +58.23% | 1 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $73 → $79 | $31.89 | +147.73% | 3 | Feb 23, 2024 |
Solventum
Feb 28, 2025
Maintains: Equal-Weight
Price Target: $73 → $75
Current: $65.70
Upside: +14.16%
DENTSPLY SIRONA
Feb 28, 2025
Maintains: Equal-Weight
Price Target: $20 → $19
Current: $12.84
Upside: +47.98%
Masimo
Feb 26, 2025
Maintains: Overweight
Price Target: $193 → $205
Current: $152.40
Upside: +34.51%
Globus Medical
Feb 21, 2025
Maintains: Overweight
Price Target: $95 → $93
Current: $72.35
Upside: +28.54%
Align Technology
Feb 14, 2025
Initiates: Overweight
Price Target: $255
Current: $171.41
Upside: +48.77%
Henry Schein
Feb 14, 2025
Initiates: Equal-Weight
Price Target: $80
Current: $64.28
Upside: +24.46%
CONMED
Feb 6, 2025
Maintains: Equal-Weight
Price Target: $74 → $70
Current: $48.54
Upside: +44.21%
Envista Holdings
Feb 6, 2025
Maintains: Equal-Weight
Price Target: $20 → $21
Current: $15.19
Upside: +38.25%
NeuroPace
Nov 13, 2024
Maintains: Overweight
Price Target: $15 → $13
Current: $10.80
Upside: +20.37%
Alphatec Holdings
Aug 1, 2024
Maintains: Overweight
Price Target: $26 → $19
Current: $10.54
Upside: +80.35%
May 7, 2024
Downgrades: Equal-Weight
Price Target: $45 → $25
Current: $15.80
Upside: +58.23%
Feb 23, 2024
Maintains: Overweight
Price Target: $73 → $79
Current: $31.89
Upside: +147.73%